(Press-News.org) There is something sinister about epilepsy: the disease affects the very core of our being, our brain. Epileptic attacks can lead to seizures throughout the body or in parts of it. Clouding of consciousness or memory lapses are also possible. The causes are still only partially understood but in some cases brain tumours, infections, inflammations of the brain or metabolic diseases have been implicated.
Epilepsy is not confined to humans and many animals also suffer from it. Together with partners in Oxford and Budapest, Akos Pakozdy and his colleagues at the University of Veterinary Medicine, Vienna have managed to identify the cause of a certain form of epilepsy in cats, in which the body's own immune system attacks particular proteins in the cell membranes of nerve cells. The symptoms include twitching facial muscles, a fixed stare, chewing motions and heavy dribbling. Based on their clinical experience, the researchers believe that this form of epilepsy is fairly widespread in cats. Interestingly, a highly similar type of epilepsy occurs in humans: an inflammation in the brain, known as limbic encephalitis, leads to epileptic seizures that generally manifest themselves in the arm and the facial muscles on only one side of the body.
Pakozdy and his colleagues have found antibodies in the blood of epileptic cats that react to proteins in the cell membranes of nerve cells. The proteins form the building blocks of ion channels that are involved in the production of nerve signals. The same ion channels are affected in the corresponding human form of epilepsy. They control the membrane's permeability to potassium ions based on the electric potential across the membrane, thereby helping generate the rapid nerve signals of the so-called action potential.
Immunotherapy for cats?
If the immune system attacks components of these ion channels, the production of nerve signals is disrupted. There is an increased release of neurotransmitters, which leads directly to the symptoms of epilepsy. Previous work – in another group – on human patients has shown that normal anti-epilepsy medication has hardly any effect on this form of epilepsy. However, immunotherapy has proven to be relatively effective. Pakozdy's work now shows that "limbic encephalitis in cats has the same cause as it does in humans, where the origins have been known for years. It is important that cats with epilepsy are diagnosed early, so that the correct form of therapy can be started. We believe this will dramatically increase the chances of a successful treatment. It seems as though epileptic cats might benefit from treatment with immune preparations."
### The article Suspected Limbic Encephalitis and Seizure in Cats Associated with Voltage-Gated Potassium Channel (VGKC) Complex Antibody by A. Pakozdy, P. Halasz, A. Klang, J. Bauer, M. Leschnik, A. Tichy, J.G. Thalhammer, B. Lang and A. Vincent is published in the current issue of the Journal of Veterinary Internal Medicine (J. Vet. Intern. Med. 2013(27), 212-214).
A summary of the original article is available online at
http://onlinelibrary.wiley.com/doi/10.1111/jvim.12026/abstract
The full text is available for purchase or by subscription.
Press release to a previous article by the research team, in which the symptoms of epilepsy in cats were described:
http://www.vetmeduni.ac.at/de/infoservice/aktuelles/presseinformationen/presseinfo2011/pakozdy-epillepsie-katze/
Scientific contact:
Dr Akos Pakozdy
Clinical Department for Internal Medicine of Small Animals
University of Veterinary Medicine, Vienna (Vetmeduni Vienna)
Tel. +43 664 60257-6866
akos.pakozdy@vetmeduni.ac.at
Contact:
Klaus Wassermann
Public Relations/Science Communications
University of Veterinary Medicine, Vienna (Vetmeduni Vienna)
Tel. +43 1 25077-1153
klaus.wassermann@vetmeduni.ac.at
Cats and humans suffer from similar forms of epilepsy
2013-02-02
ELSE PRESS RELEASES FROM THIS DATE:
Caring friends can save the world
2013-02-02
This press release is available in French.
Montreal, February 1, 2012 – Craig Kielburger was only 12 years old when he travelled to India to see the plight of child laborers first hand. 14-year-old Malala Yousafzai took a stand against the Taliban with her campaign for women's education rights. Alongside these individuals, organizations like Teenactivist.org and Dosomething.org rally teens to make a difference in their communities and beyond.
Of course, it's not every teenager who will step forward and get involved. Under the right conditions, however, the desire ...
Autism speaks through gene expression
2013-02-02
Philadelphia, Pa. – Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis and treatment. New work to examine which genes are responsible for autism disorders will be presented at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa.
"Autism is the most inheritable of neurodevelopmental disorders," explains Rajini Rao of Johns Hopkins University in Baltimore, ...
Group Therapy: New approach to psychosis treatment could target multiple nervous system receptors
2013-02-02
Philadelphia, Pa. – Antipsychotic drugs, used in the treatment of psychotic disorders involving severe delusions and hallucinations, have been studied for more than 70 years. Currently available antipsychotic drugs, however, only alleviate certain symptoms, with results that vary greatly from patient to patient and frequently cause significant side effects.
A new understanding of how the brain's G-protein receptors work may soon enable a way to better customize and target antipsychotic drugs to treat specific symptoms. Researchers from Virginia Commonwealth University ...
Imaging unveils temperature distribution inside living cells
2013-02-02
Philadelphia, Pa. – A research team in Japan exploring the functions of messenger ribonucleic acid (mRNA) – a molecule that encodes the chemical blueprint for protein synthesis – has discovered a way to take a close look at the temperature distribution inside living cells. This discovery may lead to a better understanding of diseases, such as cancer, which generate extraordinary intracellular heat.
This breakthrough is the first time anyone has been able to show the actual temperature distribution inside living cells. The team will present its findings at the 57th Annual ...
Listening to cells: Scientists probe human cells with high-frequency sound
2013-02-02
Philadelphia, Pa. – Sound waves are widely used in medical imaging, such as when doctors take an ultrasound of a developing fetus. Now scientists have developed a way to use sound to probe tissue on a much tinier scale. Researchers from the University of Bordeaux in France deployed high-frequency sound waves to test the stiffness and viscosity of the nuclei of individual human cells. The scientists predict that the probe could eventually help answer questions such as how cells adhere to medical implants and why healthy cells turn cancerous.
"We have developed a new non-contact, ...
The nanomechanical signature of breast cancer
2013-02-02
Philadelphia, Pa. – The texture of breast cancer tissue differs from that of healthy tissue. Using a cutting-edge tissue diagnostic device, a group of researchers in Basel, Switzerland, has determined one key difference: cancerous tissue is a mix of stiff and soft zones, whereas healthy tissue has uniform stiffness. This new finding may one day help improve breast cancer diagnosis and therapy by providing a unique nanomechanical signature of tumor tissue properties that indicates the potential for the cancer to spread. The team will present its work at the 57th Annual Meeting ...
Type II diabetes and the Alzheimer's connection
2013-02-02
Philadelphia, Pa. – A research team in Israel has devised a novel approach to identifying the molecular basis for designing a drug that might one day decrease the risk diabetes patients face of developing Alzheimer's disease. The team will present its work at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa.
A recent study suggests that people who suffer from type 2 diabetes face twice the risk of developing Alzheimer's disease later in life compared to those who do not have diabetes. The link these diseases share relates ...
Cooperators can coexist with cheaters, as long as there is room to grow
2013-02-02
Philadelphia, Pa. – Microbes exhibit bewildering diversity even in relatively tight living quarters. But when a population is a mix of cooperators, microbes that share resources, and cheaters, those that selfishly take yet give nothing back, the natural outcome is perpetual war. A new model by a team of researchers from Princeton University in New Jersey and Ben-Gurion University in Israel reveals that even with never-ending battles, the exploiter and the exploited can survive, but only if they have room to expand and grow. The researchers present their findings at the ...
Tracking the evolution of antibiotic resistance
2013-02-02
Philadelphia, Pa. – With the discovery of antibiotics, medicine acquired power on a scale never before possible to protect health, save lives, and reduce suffering caused by certain bacteria. But the power of antibiotics is now under siege because some virulent infections no longer respond to antibiotic drugs.
This antibiotic resistance is an urgent public health threat that a team of researchers from Sabanci University in Istanbul, Turkey, and Harvard Medical School and Harvard University in Cambridge, Mass., aim to stop. Their approach is based on an automated device ...
Propping open the door to the blood brain barrier
2013-02-02
Philadelphia, Pa. – The treatment of central nervous system (CNS) diseases can be particularly challenging because many of the therapeutic agents such as recombinant proteins and gene medicines are not easily transported across the blood-brain barrier (BBB). Focused ultrasound can be used to "open the door" of the blood brain barrier. However, finding a way to "prop the door open" to allow therapeutics to reach diseased tissue without damaging normal brain tissue is the focus of a new study by a team of researchers at the Institute of Biomedical Engineering at National ...